What are the core factual disputes and the financial stakes in Bank of Baroda v Neopharma, NMC Healthcare, and Bavaguthu Raghuram Shetty?
The lawsuit, filed under case number CFI 043/2020, represents a significant commercial litigation matter involving the Bank of Baroda (DIFC Branch) as the Claimant against a group of corporate entities and an individual defendant. The Respondents include Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty. While the specific quantum of the claim is not detailed in this procedural order, the involvement of major healthcare entities and high-profile individual defendants suggests a complex banking dispute involving substantial financial exposure.
The litigation centers on the enforcement of financial obligations and potential liabilities arising from the banking relationship between the Claimant and the Respondents. The court’s intervention through a Case Management Order (CMO) indicates that the parties have moved past the initial pleading stages and are now engaged in the rigorous process of evidence gathering and trial preparation. As noted in the procedural requirements for trial preparation:
For the Trial Bundle preparation, the parties shall provide the Claimant exhibits cross-reference to significant documents, pleadings and witness statements by no later than 4 pm on Friday, 7 July 2023. 19.
The dispute requires the court to manage a multi-party environment where document production and witness testimony are critical to determining the liability of each defendant, including the individual liability of Bavaguthu Raghuram Shetty.
Which judge presided over the Case Management Conference for Bank of Baroda v Neopharma and in which DIFC division was it heard?
The Case Management Conference for this matter was presided over by H.E. Justice Nassir Al Nasser. The proceedings were conducted within the DIFC Court of First Instance. The conference took place on 27 September 2022, and the resulting Case Management Order was formally issued on 17 October 2022 by Assistant Registrar Delvin Sumo, following the judicial review of the Case Management Bundle and the relevant Rules of the DIFC Courts (RDC).
What were the positions of the Claimant and Respondents regarding the procedural timeline in CFI 043/2020?
Counsel for the Claimant, Bank of Baroda (DIFC Branch), and Counsel for the Respondents, Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty, appeared before H.E. Justice Nassir Al Nasser to settle the procedural roadmap for the litigation. The parties adopted a collaborative approach, resulting in a consent order that governs the progression of the case.
The Respondents’ position, aligned with the Claimant’s, focused on establishing a structured framework for document production and the exchange of evidence to ensure the trial could proceed efficiently. Both sides agreed to specific deadlines for the Request to Produce process, which is a critical phase in banking litigation where internal records are often the primary evidence. As stipulated in the order regarding the initial request phase:
The parties shall file and serve a Request to Produce, if any, by 4pm on Thursday, 16 February 2023. 3.
By consenting to these terms, the parties effectively mitigated the risk of interlocutory disputes regarding disclosure, allowing the court to focus on the substantive merits of the banking claim.
What legal questions did the court address in the Case Management Order of 17 October 2022?
The primary legal question before the court was the establishment of a robust procedural framework under the Rules of the DIFC Courts (RDC) to facilitate the fair and efficient resolution of the dispute. Specifically, the court had to determine the appropriate timelines for disclosure, witness evidence, and expert testimony that would allow both parties adequate time to prepare their cases while ensuring the trial date of 11 September 2023 remained viable. The court also had to address the mechanics of document production, including the process for handling objections to requests for production, to prevent procedural delays.
How did H.E. Justice Nassir Al Nasser apply the RDC to structure the evidence exchange in this matter?
H.E. Justice Nassir Al Nasser utilized the RDC to create a sequential, logical flow of evidence. The judge ensured that the disclosure of documents preceded the exchange of witness statements, which in turn preceded the filing of expert reports. This structure is designed to ensure that witnesses and experts are fully informed by the documentary evidence before finalizing their testimony. The judge also implemented a clear mechanism for reply evidence to ensure that the court receives a balanced view of the facts. Regarding the timeline for witness evidence, the order states:
Signed statements of witnesses of fact, and hearsay notices where required by the RDC shall be exchanged 4 weeks following the close of the disclosure stage, and in any event by 4pm on Friday, 7 April 2023. 9.
Furthermore, the judge provided for a reply stage to ensure that any new issues raised in the initial witness statements could be addressed before the trial:
Any Witness Statement evidence in reply shall be filed and served in within 21 days thereafter, and in any event by 4pm on Monday, 08 May 2023. 10.
Which specific RDC rules were invoked to govern the procedural conduct of Bank of Baroda v Neopharma?
The court relied on several key parts of the Rules of the DIFC Courts (RDC) to manage the litigation. These include:
* RDC Part 28: Governing the production of documents and the disclosure process.
* RDC Part 29: Regulating the exchange of witness statements and hearsay notices.
* RDC Part 31: Setting the framework for the appointment of experts and the submission of expert reports.
* RDC Part 35: Providing the rules for trial preparation, including the creation of trial bundles, skeleton arguments, and the trial timetable.
* RDC Part 26: Managing the progress monitoring and the pre-trial review process.
* RDC 23: Establishing the procedure for making applications to the court, particularly regarding document production disputes.
How did the court utilize the RDC to manage expert evidence and trial preparation?
The court utilized RDC Part 31 to ensure that expert evidence is introduced in a timely and transparent manner. The parties are required to disclose the names, qualifications, and fields of expertise of their experts by 10 May 2023, followed by the service of reports in June 2023. This allows the court to manage the complexity of the banking issues involved. Regarding the identification of experts, the order specifies:
The parties shall provide to each other and to the Registry the names, field(s) of expertise and qualifications of their respective expert(s) no later than 4pm on Wednesday, 10 May 2023. 13.
Additionally, the court used RDC Part 35 to mandate the creation of an agreed chronology and trial timetable, which is essential for managing a trial estimated to last between three and four days. The parties are required to agree on these documents by 11 July 2023, as noted in the order:
For the Trial Bundle preparation, the parties shall agree to the Chronology of significant events and an estimated Trial Timetable by no later than 4 pm on Tuesday, 11 July 2023. 16.
What was the final disposition of the Case Management Conference and how were costs allocated?
The court issued a comprehensive Case Management Order by consent, which serves as the binding procedural schedule for the parties. The order sets out a detailed calendar of deadlines, culminating in a trial scheduled to commence at 12 noon on 11 September 2023. Regarding the costs of the application, the court ordered that the costs of the Case Management Order are to be "costs in the case," meaning they will be determined at the conclusion of the litigation based on the final judgment.
What are the wider implications of this order for DIFC practitioners managing complex banking litigation?
This case serves as a template for how the DIFC Courts manage high-stakes, multi-party commercial disputes. Practitioners should note the court's emphasis on the "Request to Produce" process as a distinct phase that must be completed before witness statements are exchanged. The strict adherence to the RDC timelines—particularly the use of "in any event" deadlines—signals that the court expects parties to manage their internal document review processes efficiently. Litigants must anticipate that the court will strictly enforce these dates to maintain the trial window, and any failure to comply with the disclosure or witness statement deadlines will likely result in the need for further, potentially costly, applications to the court.
Where can I read the full judgment in Bank of Baroda v Neopharma [2022] DIFC CFI 043?
The full Case Management Order can be accessed via the DIFC Courts website: https://www.difccourts.ae/rules-decisions/judgments-orders/court-first-instance/cfi-0432020-bank-baroda-difc-branch-v-1-neopharma-llc-2-nmc-healthcare-llc-3-new-medical-centre-llc-4-bavaguthu-raghuram-shetty-1. The document is also available via the CDN link: https://littdb.sfo2.cdn.digitaloceanspaces.com/litt/AE/DIFC/judgments/court-first-instance/DIFC_CFI-043-2020_20221017.txt
Cases referred to in this judgment:
| Case | Citation | How used |
|---|---|---|
| N/A | N/A | No specific case law precedents were cited in this procedural order. |
Legislation referenced:
- Rules of the DIFC Courts (RDC) Part 23
- Rules of the DIFC Courts (RDC) Part 26
- Rules of the DIFC Courts (RDC) Part 28
- Rules of the DIFC Courts (RDC) Part 29
- Rules of the DIFC Courts (RDC) Part 31
- Rules of the DIFC Courts (RDC) Part 35